Image Ben Hargreaves Sales & Marketing ADHD medication scarcity adds to questions on US supply chai... Ben Hargreaves looks into why ADHD medicines are still suffering shortages nearly a year after first being announced. Sales & Marketing All eyes remain on US government patent dispute with Gilead A high-stakes court battle is currently being fought in the US, with the government accusing a big pharma company of patent infringement for the first time. Sales & Marketing Pandemic caused vaccine confidence to fall even further Research has shown that vaccine hesitancy is on the rise globally. R&D Oncology R&D hits new heights, but that creates problems The number of people globally who are being treated for cancer is steadily going up each year. Load more results
Sales & Marketing ADHD medication scarcity adds to questions on US supply chai... Ben Hargreaves looks into why ADHD medicines are still suffering shortages nearly a year after first being announced.
Sales & Marketing All eyes remain on US government patent dispute with Gilead A high-stakes court battle is currently being fought in the US, with the government accusing a big pharma company of patent infringement for the first time.
Sales & Marketing Pandemic caused vaccine confidence to fall even further Research has shown that vaccine hesitancy is on the rise globally.
R&D Oncology R&D hits new heights, but that creates problems The number of people globally who are being treated for cancer is steadily going up each year.
News Isomorphic Labs raises $5bn in massive third round In yet another sign of the appetite for AI companies among investors, Isomorphic Labs has raised a whopping $5bn in a Series C financing.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.